← Back to All Filings

MeiraGTx Officer Files Intent to Sell $213K in Company Stock

Low SignificanceOctober 21, 2025 at 9:31:36 PM EDT

MeiraGTx Holdings plc

$MGTX144CIK: 0001735438

Subscribe to track MGTX

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

MeiraGTx Officer Files Intent to Sell $213K in Company Stock

Company: MeiraGTx Holdings plc (MGTX) Form: 144 | Filed: 2025-10-21 Significance: Low

Insider: Richard Giroux Title: Officer | Relationship: Officer

Transaction: • Type: Proposed Sale • Shares: 24,000 • Price: ~$8.87 • Value: $212,880 • Owned After: Not Disclosed

Key Insight: An officer has filed a notice of proposed sale for shares valued at $212,880. The transaction size is minor, representing approximately 0.03% of both market cap and shares outstanding, indicating low trading significance. The sale is planned under a trading plan adopted on August 29, 2024.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: MeiraGTx Holdings plc (MGTX)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An officer of MeiraGTx Holdings has filed a notice of proposed sale for 24,000 shares, valued at approximately $212,880. The transaction's size is not material relative to the company's market capitalization or total shares outstanding.
  • Market Impact: The sale is unlikely to have a significant impact on the stock price due to its small size.

Company Information

FieldValue
CompanyMeiraGTx Holdings plc
Ticker SymbolMGTX
CIK0001735438
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameRichard Giroux
CIK0001742734
Title/PositionOfficer
RelationshipOfficer

Transaction Details

FieldValue
Form Type144
Transaction Date2025-10-21 (Approximate Sale Date)
Transaction CodeS (Proposed Sale)
Security TypeOrdinary Shares
Shares Involved24,000
Price Per Share$8.87
Total Value$212,880
Shares Owned AfterNot Disclosed
Ownership TypeNot Disclosed

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$212,880
% of Market Cap0.034%
Shares Transacted24,000
% of Shares Outstanding0.030%
Post-Transaction OwnershipNot Disclosed
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: MeiraGTx Holdings has a market capitalization of approximately $620 million. The $212,880 proposed sale represents a very small fraction (0.034%) of the company's total market value, making it financially insignificant from a market perspective.
  • Ownership Concentration: Post-transaction ownership details are not available in a Form 144 filing, so the impact on the insider's total holdings cannot be assessed.
  • Dilution Impact: This is a secondary market sale of existing shares, not an issuance of new equity, so there is no dilution impact on existing shareholders.
  • Transaction Significance: The sale constitutes just 0.030% of the total shares outstanding. Both the value and volume percentages fall well below the thresholds for moderate or high significance, classifying this as a routine, low-impact transaction.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is too small to signal a significant change in insider sentiment or to create meaningful selling pressure on the stock. It is likely motivated by personal financial planning rather than a change in outlook on the company's future.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The 24,000 shares are unlikely to cause a noticeable spike in trading volume.
  • Sentiment Indicator: Neutral. Given the small size and the fact it's filed under a pre-arranged trading plan, the market is unlikely to interpret this sale as a bearish signal.

Investment Insights

Positive Market Indicators

  • N/A. This filing does not present positive indicators.

Risk Factors

  • N/A. This specific transaction does not introduce new risk factors.

Key Takeaways

  1. Low Materiality: The proposed sale by Officer Richard Giroux is minor, representing less than 0.04% of the company's market cap.
  2. Pre-Planned Sale: The filing notes a plan adoption date of August 29, 2024, suggesting this is a pre-scheduled sale under a Rule 10b5-1 plan, which reduces its significance as an indicator of current insider sentiment.
  3. No Market Impact Expected: Due to the small size and pre-planned nature of the sale, no significant market reaction is anticipated.

Additional Context

Transaction Notes

  • Form 144: This form is a notice of proposed sale of securities, not a confirmation of a completed trade like a Form 4. The sale is expected to occur on or around October 21, 2025.
  • Special Circumstances: The sale is being conducted under a trading plan adopted nearly two months prior to the filing date, which is a standard practice for insiders to liquidate shares for personal reasons without being accused of trading on non-public information.
Topics:#SECFiling#InsiderTrading#Form144#MGTX#MeiraGTx#InsiderSell#StockMarket#Biotechnology

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.